uniQure (QURE) Long-Term Deferred Tax (2020 - 2026)
uniQure (QURE) recorded quarterly Long-Term Deferred Tax of $8.2 million in Q1 2026, down 5.32% quarter-over-quarter from $8.7 million in Q4 2025, and down 12.74% on a YoY basis from $9.4 million in Q1 2025.
uniQure (QURE) Long-Term Deferred Tax (2020 - 2026) Analysis & Trends
uniQure's Long-Term Deferred Tax history runs 7 years deep, the most recent figure standing at $8.2 million for Q1 2026.
- In Q1 2026, Long-Term Deferred Tax fell 12.74% year-over-year to $8.2 million; the TTM figure through Mar 2026 stood at $8.2 million (down 12.74% YoY), while the FY2025 annual figure was $8.7 million, down 12.2% from the prior year.
- Long-Term Deferred Tax was $8.2 million for Q1 2026 at uniQure, down from $8.7 million in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $15.4 million in Q1 2022 to a low of $8.2 million in Q1 2026.
- Historically, Long-Term Deferred Tax has averaged $11.7 million across 5 years, with a median of $11.6 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Long-Term Deferred Tax slipped 4.71% in 2022, then retreated 23.42% in 2024.
- A 5-year view of Long-Term Deferred Tax shows it stood at $14.5 million in 2022, then dropped by 15.5% to $12.3 million in 2023, then dropped by 19.71% to $9.9 million in 2024, then decreased by 12.2% to $8.7 million in 2025, then declined by 5.32% to $8.2 million in 2026.
- The last three Long-Term Deferred Tax figures came in at $8.2 million (Q1 2026), $8.7 million (Q4 2025), and $8.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.19 Mn |
| Dec 31, 2025 | 8.65 Mn |
| Sep 30, 2025 | 8.77 Mn |
| Jun 30, 2025 | 9.02 Mn |
| Mar 31, 2025 | 9.39 Mn |
| Dec 31, 2024 | 9.86 Mn |
| Sep 30, 2024 | 10.86 Mn |
| Jun 30, 2024 | 10.72 Mn |
| Mar 31, 2024 | 11.59 Mn |
| Dec 31, 2023 | 12.28 Mn |
| Sep 30, 2023 | 12.35 Mn |
| Jun 30, 2023 | 14.00 Mn |
| Mar 31, 2023 | 14.33 Mn |
| Dec 31, 2022 | 14.53 Mn |
| Sep 30, 2022 | 14.63 Mn |
| Jun 30, 2022 | 15.05 Mn |
| Mar 31, 2022 | 15.44 Mn |
| Dec 31, 2021 | 15.65 Mn |
| Sep 30, 2021 | 15.72 Mn |
| Jun 30, 2021 | 15.97 Mn |